ASML vs CTS

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

CTS Corporation exhibits exceptional fundamental health, highlighted by a strong Piotroski F-Score of 8/9 and a very low Debt/Equity ratio of 0.15. While the stock trades significantly above its defensive Graham Number ($30.75), it remains below its growth-based intrinsic value of $64.61. However, the outlook is tempered by a bearish technical trend (10/100), recent insider selling by the CFO, and a current price that has slightly exceeded the sole analyst's target of $54.00. The company is a high-quality operator currently facing a valuation and sentiment ceiling.